在标准风险患者中对横动脉复血管化的前性多中心评估:ROADSTER 3研究的30天结果
Jeffrey Jim1, Meghan Dermody2, Brian Peterson3
1Vascular and Endovascular Surgery, Minneapolis Heart Institute, Minneapolis, MN.
Annals of neurology
|November 24, 2025
概括
超动脉再血管化 (TCAR) 对于额外内动脉疾病的标准手术风险患者来说是安全有效的. ROADSTER 3研究证实,在30天内中风,死亡或心肌梗塞的发生率很低.
科学领域:
- 血管外科 血管外科
- 神经学 神经学
- 干预心脏病学 干预心脏病学
背景情况:
- 额外内动脉疾病带来很大的中风风险.
- 穿动脉复血管化 (TCAR) 是治疗这些疾病的动脉内关节切除术的替代方案.
- 现实世界的数据对于评估TCAR在标准风险患者的安全性和有效性至关重要.
研究的目的:
- 评估TCAR的现实安全性和有效性.
- 为了评估标准手术风险和额外内动脉疾病的患者的结果.
- 为了确定TCAR后30天重大不良事件的发生率.
主要方法:
- 预期的,多中心的,单臂的批准后研究 (ROADSTER 3).
- 包括没有高风险因素的80岁以下患者.
- 评估30天的主要不良事件 (中风,死亡,心肌梗塞) 和神经损伤.
主要成果:
- 在320名每项方案的患者中,技术成功率为100%.
- 在每项方案的人群中,30天中风/死亡/心肌梗塞的复合率为0.6%.
- 暂时神经损伤的发生率为0.6%,在6个月内完全消失.
结论:
- 证实TCAR对于额外内动脉疾病的标准风险患者是安全有效的.
- 这项研究支持TCAR作为这种患者队列的可行治疗选择.
- 需要长期的随访,以确认持久的中风预防.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
502
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747


